AstraZeneca COVID-19 vaccine study paused after one illness

CTV News

08 Sep 2020 0 shares 1 views

AstraZeneca COVID-19 vaccine study paused after one illness

CTV News

Published 08 Sep 2020

Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates if a report of a patient with a serious side effect is linked to the shot.

Full Article

FDA to widen US safety inquiry into AstraZeneca COVID vaccine, sources say

Brisbane Times 30 Sep 2020

The US regulator has broadened its investigation of a serious illness in AstraZeneca's COVID-19 vaccine study and will look at data..

Coronavirus could turn into a seasonal virus, but it will keep spreading until the population achieves herd immunity, say experts
NaturalNews.com 27 Sep 2020
Late-stage study of first single-shot vaccine begins in US
SeattlePI.com 23 Sep 2020
Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine
Mid-Day 16 Sep 2020
AstraZeneca To Resume COVID-19 Vaccine Study After Pause Caused By Serious Symptoms In Patient
Daily Caller 14 Sep 2020

More coverage

Oxford, AstraZeneca resumes coronavirus vaccine trial

SeattlePI.com 12 Sep 2020

LONDON (AP) — Oxford University announced Saturday it was resuming a trial for a coronavirus vaccine it is developing with..

Oxford, AstraZeneca to resume coronavirus vaccine trial
SeattlePI.com 12 Sep 2020
Vaccine trial stopped after neurological symptoms detected
SeattlePI.com 10 Sep 2020
Serum Institute puts India trials of AstraZeneca's Covid-19 vaccine on hold
Khaleej Times 10 Sep 2020
Coronavirus outbreak: Serum Institute pauses COVID-19 vaccine trials in India
Mid-Day 10 Sep 2020

AstraZeneca COVID-19 vaccine study paused after one illness

AstraZeneca COVID-19 vaccine study paused after one illness

You might like

Related news coverage

FDA to widen US safety inquiry into AstraZeneca COVID vaccine, sources say

Advertisement

More coverage

Oxford, AstraZeneca resumes coronavirus vaccine trial